P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

October 2006

Features

Letter to the Editor

HRT: Natural versus Synthetic

Joe Jeffries, RPh

Costs Associated with Candidemia in a Hospital Setting

The authors conducted a retrospective cohort study at their institution to determine the inpatient care cost of treating candidemia, the leading cause of fungal infections in hospitalized patients.
Joshua J. Gagne, PharmD, Ross E. Breitbart, MS, Vittorio Maio, PharmD, MS, MSPH, David L. Horn, MD, Christine W. Hartmann, MSS, PhD, Robert Swanson, PhD, and Neil I. Goldfarb

Dose–Conversion Ratio for Epoetin Alfa and Darbepoetin Alfa in Chemotherapy Patients with Anemia and Cancer

The authors present the findings of a study that was designed to compare the effectiveness and equivalence of two erythropoietic agents based on a randomized, prospective clinical trial.
Antoine Gosselin, MA, R. Scott McKenzie, MD, Patrick Lefebvre, MA, Samir H. Mody, PharmD, MBA, Catherine Tak Piech, MBA, and Mei Sheng Duh, MPH, ScD

Continuing Education Credit

Cardiovascular Effects of COX-2 Inhibitors: A Review of the Literature

In multiple trials and analyses, the incidence of cardiovascular events has been higher with coxibs than with placebo and other nonselective NSAIDs. Although an explanation for these events has not yet been determined, several theories relate to physiological mechanisms, drug selectivity or structure, doses and duration of clinical trials, and the influence of underlying disease states.
Craig D. Cox, PharmD, BCPS, Brad L. Stanford, PharmD, BCOP, James P. Tsikouris, PharmD, Michael J. Peeters, PharmD, BCPS, and Gary Meyerrose, MD

Departments

Editorial

Leadership

David Nash, MD, MBA, illustrates the importance of one executive’s commitment to developing new leaders and emphasizes the need for the health care industry to recognize this challenge.
David Nash, MD, MBA

Prescription: Washington

Drug Pedigrees and Distribution Dilemmas: FDA’s New Requirements May Disrupt Pharmacy–Wholesaler Relationships

Stephen Barlas explains a new FDA anti-counterfeiting measure that will require pharmacies to obtain a drug “pedigree” from wholesalers who are not authorized distributors.
Stephen Barlas

Medication Errors

“Smart” Infusion Pumps Join CPOE and Bar Coding as Ways to Prevent Medication Errors

Matthew Grissinger, RPh, FASCP, discusses the technology of “smart” infusion pumps that will aid hospitals in the effort to reduce mistakes.
Matthew Grissinger, RPh, FASCP

New Drugs/Drug News/New Medical Devices

P&T presents the latest information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Pregabalin (Lyrica): A New Treatment Option for Neuropathic Pain and Partial Seizures

The authors review pregabalin (Lyrica) for neuropathic pain and partial seizures.
Jason N. Roe, PharmD, Edanai M. Velez, PharmD Candidate, and Jose A. Rey, PharmD